| Literature DB >> 35709124 |
Sun Do Kim1, Geun-Bae Kim1, Gi Yong Lee1, Soo-Jin Yang2.
Abstract
Sequence type (ST) 5 methicillin-resistant Staphylococcus aureus (MRSA) with staphylococcal cassette chromosome mec (SCCmec) type II (ST5-MRSA-II) and ST72-MRSA-IV represent the most significant genotypes for healthcare- (HA) and community-associated (CA) MRSA in Korea, respectively. In addition to the human-type MRSA strains, the prevalence of livestock-associated (LA) MRSA clonal lineages, such as ST541 and ST398 LA-MRSA-V in pigs and ST692 LA-MRSA-V and ST188 LA-MRSA-IV in chickens, has recently been found. In this study, clonotype-specific resistance profiles to cathelicidins derived from humans (LL-37), pigs (PMAP-36), and chickens (CATH-2) were examined using six different ST groups of MRSA strains: ST5 HA-MRSA-II, ST72 CA-MRSA-IV, ST398 LA-MRSA-V, ST541 LA-MRSA-V, ST188 LA-MRSA-IV, and ST692 LA-MRSA-V. Phenotypic characteristics often involved in cathelicidin resistance, such as net surface positive charge, carotenoid production, and hydrogen peroxide susceptibility were also determined in the MRSA strains. Human- and animal-type MRSA strains exhibited clonotype-specific resistance profiles to LL-37, PMAP-36, or CATH-2, indicating the potential role of cathelicidin resistance in the adaptation and colonization of human and animal hosts. The ST5 HA-MRSA isolates showed enhanced resistance to all three cathelicidins and hydrogen peroxide than ST72 CA-MRSA isolates by implementing increased surface positive charge and carotenoid production. In contrast, LA-MRSA strains employed mechanisms independent of surface charge regulation and carotenoid production for cathelicidin resistance. These results suggest that human- and livestock-derived MRSA strains use different strategies to counteract the bactericidal action of cathelicidins during the colonization of their respective host species. © Copyright 2022 Korean Society of Animal Science and Technology.Entities:
Keywords: Cathelicidin; Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA); Healthcare-associated methicillin-resistant Staphylococcus aureus (HA-MRSA); Host adaptation; Livestock-associated methicillin-resistant Staphylococcus aureus (LA-MRSA); Methicillin-resistant Staphylocuccus aureus
Year: 2022 PMID: 35709124 PMCID: PMC9184701 DOI: 10.5187/jast.2022.e32
Source DB: PubMed Journal: J Anim Sci Technol ISSN: 2055-0391
Genotype and antimicrobial resistance profiles of MRSA strains used in this study
| MLST | Strain ID |
| SCC |
| Antimicrobial resistance profiles | OX MIC (μg/mL) |
|---|---|---|---|---|---|---|
| ST5 (n = 8) | HA1 | t002 | II | II | AMP-CIP-CLI-ERY-FOX-PEN | 512 |
| HA2 | t601 | II | II | AMP-CIP-CLI-ERY-FOX-PEN | 512 | |
| HA3 | t2460 | II | II | AMP-CIP-CLI-ERY-FOX-FUS-GEN-PEN-RIF | 512 | |
| HA4 | t2460 | II | II | AMP-CIP-CLI-ERY-FOX-FUS-GEN-PEN | 512 | |
| HA5 | t002 | II | II | AMP-CIP-CLI-ERY-FOX-FUS-GEN-PEN | 512 | |
| HA6 | t601 | II | II | AMP-CIP-CLI-ERY-FOX-PEN | 512 | |
| HA7 | t2460 | II | II | AMP-CIP-CLI-ERY-FOX-FUS-PEN-RIF | 512 | |
| HA8 | t601 | II | II | AMP-CIP-CLI-ERY-FOX-PEN | 512 | |
| ST72 (n = 11) | CA1 | t324 | IV | I | AMP-ERY-FOX-PEN | 32 |
| CA2 | t13921 | IV | I | AMP-FOX-PEN | 64 | |
| CA3 | t664 | IV | I | AMP-FOX-PEN | 64 | |
| CA4 | t2461 | IV | I | AMP-FOX-PEN | 32 | |
| CA5 | t324 | IV | I | AMP-ERY-FOX-PEN | 64 | |
| CA6 | t148 | IV | I | AMP-FOX-PEN | 32 | |
| CA7 | t324 | IV | I | AMP-FOX-PEN | 32 | |
| CA8 | t324 | IV | I | AMP-FOX-PEN | 32 | |
| CA9 | t324 | IV | I | AMP-ERY-FOX-PEN-RIF | 64 | |
| CA10 | t664 | IV | I | AMP-FOX-PEN | 32 | |
| CA11 | t664 | IV | I | AMP-FOX-PEN | 32 | |
| ST398 (n = 8) | Pig1 | t571 | V | I | AMP-CHL-CIP-FOX-FUS-PEN-TET | 24 |
| Pig2 | t18103 | V | I | AMP-CHL-CIP-CLI-ERY-FOX-GEN-PEN-SYN-TET | 4 | |
| Pig3 | t18103 | V | I | AMP-CHL-CIP-CLI-ERY-FOX-GEN-PEN-SYN-TET | 4 | |
| Pig4 | t18103 | V | I | AMP-CHL-CIP-CLI-ERY-FOX-GEN-PEN-SYN-TET | 8 | |
| Pig5 | t18102 | V | I | AMP-CHL-CIP-FOX-PEN-TET | 24 | |
| Pig6 | t18102 | V | I | AMP-CHL-CIP-FOX-PEN-TET | 16 | |
| Pig7 | t18102 | V | I | AMP-CHL-CIP-FOX-PEN-TET | 16 | |
| Pig8 | t18102 | V | I | AMP-CHL-CIP-FOX-PEN-TET | 16 | |
| ST541 (n = 6) | Pig9 | t034 | V | I | AMP-CLI-ERY-FOX-PEN-TET | 32 |
| Pig10 | t034 | V | I | AMP-CLI-ERY-FOX-PEN-TET | 12 | |
| Pig11 | t034 | V | I | AMP-CLI-ERY-FOX-PEN-TET | 16 | |
| Pig12 | t034 | V | I | AMP-CLI-ERY-FOX-PEN-TET | 16 | |
| Pig13 | t034 | V | I | AMP-CLI-ERY-FOX-PEN-TET | 16 | |
| Pig14 | t034 | V | I | AMP-CLI-ERY-FOX-PEN-TET | 16 | |
| ST692 (n = 6) | Chicken1 | t2247 | V | I | AMP-CIP-CLI-ERY-FOX-PEN-TET | 128 |
| Chicken2 | t2247 | V | I | AMP-CIP-CLI-ERY-FOX-FUS-PEN-TET | 256 | |
| Chicken3 | t2247 | V | I | AMP-CIP-CLI-ERY-FOX-PEN-TET | 256 | |
| Chicken4 | t2247 | V | I | AMP-CIP-CLI-ERY-FOX-PEN-TET | 128 | |
| Chicken5 | t2247 | V | I | AMP-CIP-CLI-ERY-FOX-PEN-TET | 64 | |
| Chicken6 | t2247 | V | I | AMP-CIP-CLI-ERY-FOX-PEN-TET | 32 | |
| ST188 (n = 6) | Chicken7 | t189 | IV | I | AMP-CIP-CLI-ERY-FOX-GEN-PEN-SXT | 128 |
| Chicken8 | t189 | IV | I | AMP-CIP-CLI-ERY-FOX-GEN-PEN-SXT | 128 | |
| Chicken9 | t189 | IV | I | AMP-CIP-CLI-ERY-FOX-GEN-PEN-SXT | 128 | |
| Chicken10 | t189 | IV | I | AMP-CIP-CLI-ERY-FOX-GEN-PEN-SXT | 128 | |
| Chicken11 | t189 | IV | I | AMP-CIP-CLI-ERY-FOX-GEN-PEN-SXT | 128 | |
| Chicken12 | t189 | IV | I | AMP-CIP-CLI-ERY-FOX-GEN-PEN-SXT | 128 |
MRSA, methicillin-resistant Staphylococcus aureus; MLST, multilocus sequence typing; SCCmec, staphylococcal cassette chromosome mec; OX, oxacillin; MIC, minimum inhibitory concentration; ST, sequence type; HA, halthcare-associated; AMP, ampicillin; CIP, ciprofloxacin; CLI, clindamycin; ERY, erythromycin; FOX, cefoxitin; PEN, penicillin; FUS, fusidic acid; GEN, gentamicin; RIF, rifampicin; CA, community-associated; CHL, chloramphenicol; TET, tetracycline; SYN, quinupristin-dalfopristin; SXT, sulfamethoxazole-trimethoprim.
Fig. 1.Susceptibility profiles of the different ST groups of MRSA strains to LL-37 (A), PMAP-36 (B), and CATH-2 (C).
MRSA strains were exposed to LL-37 (10 μg/mL), PMAP-36 (1.0 μg/mL), and CATH-2 (0.5 μg/mL) and viability of the bacterial cells were determined. Data represent the means ± standard deviation of three independent experiments. Different letters indicate significant differences between the groups. ST, sequence type; MRSA, methicillin-resistant Staphylococcus aureus; LL-37, cathelicidin of humans; PMAP-36, cathelicidin of pigs; CATH-2, cathelicidin of chickens.
Fig. 2.Cytochrome c binding assays to measure comparative surface positive charges of MRSA strains.
These data represent means ± SD of three independent experiments. *p < 0.05, **p < 0.01. ST, sequence type; MRSA, methicillin-resistant Staphylococcus aureus.
Fig. 3.Measurement of staphyloxanthin production in different ST groups of MRSA strains.
Bars represent the means ± SD of three independent experiments. *p < 0.05, **p < 0.01. OD, optical density; ST, sequence type; MRSA, methicillin-resistant Staphylococcus aureus.
Fig. 4.Survival of different ST groups of MRSA strains against hydrogen peroxide.
MRSA cells (~2.0×109 CFUs) were incubated with H2O2 (1.5% final concentration) at 37°C for 2 h and surviving bacterial cells were enumerated on TSA plates. Bars represent the mean % of surviving CFU ± SDs of H2O2-treated versus untreated cells. *p < 0.05, **p < 0.01. ST, sequence type; MRSA, methicillin-resistant Staphylococcus aureus.